Contineum Therapeutics, Inc

CTNMNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

23.1M

on 2025-10-27, from 2.38M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2025-05-14. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Leerink Partners, agreement of 2025-05-14. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-07-30 is not read yet.

Cash

17.9 quarters

$236.6M on 2026-06-30 ÷ $13.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-12-11	Public offering	not read	$12.25	$90.0M	424B5 ↗